HXL vs PFE · P/E 59, rev $529.3M vs P/E 20, rev $15.03B
Hexcel Corporation (HXL) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Hexcel Corporation (HXL) is a aerospace & defense company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported HXL revenue for 2026-06-30 was $529.3M. Net income was $49.3M. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
HXL currently screens at market cap $6.73B and trailing P/E 59.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the HXL and PFE stock pages for the full models.
Not investment advice.